Metformin Increases Sensitivity of Pancreatic Cancer Cells to Gemcitabine by Reducing CD133+ Cell Populations and Suppressing ERK/P70S6K Signaling (Q36099266)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Metformin Increases Sensitivity of Pancreatic Cancer Cells to Gemcitabine by Reducing CD133+ Cell Populations and Suppressing ERK/P70S6K Signaling |
scientific article |
Statements
1 reference
Metformin Increases Sensitivity of Pancreatic Cancer Cells to Gemcitabine by Reducing CD133+ Cell Populations and Suppressing ERK/P70S6K Signaling (English)
1 reference
Xinqun Chai
1 reference
Hongpeng Chu
1 reference
Xuan Yang
1 reference
Yuanpu Meng
1 reference
Pengfei Shi
1 reference
Shanmiao Gou
1 reference
22 September 2015
1 reference
1 reference
22 September 2015
1 reference
Identifiers
1 reference